Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint
2021-03-29 08:27
Making Most out of Launched Products Fueling Diversified Innovation through Integrated Platform
2021-03-28 11:16
Genscript Biotech Reports Full Year 2020 Financial Results
2021-03-27 02:16
Modern Chinese Medicine Announces Year 2020 Annual Results
2021-03-26 22:08
Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years
2021-03-26 21:31
Artificial Joint Surgical Robot, CUVIS-joint developed by CUREXO Receives EEA CE Marking
2021-03-26 17:00
Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)
2021-03-26 16:00
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115
2021-03-26 08:38
Antengene Announces Financial Results for Full Year 2020
2021-03-26 08:00
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion
2021-03-26 08:00
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round
2021-03-26 05:19
Antengene Appoints Kevin Lynch as Chief Medical Officer
2021-03-25 23:26
Antengene Appoints Bo Shan as Chief Scientific Officer
2021-03-25 22:36
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020
2021-03-25 22:03
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine
2021-03-25 21:00
Össur Recognized by World Intellectual Property Organization (WIPO) as Leading Assistive Technology Development
2021-03-25 20:55
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers
2021-03-25 18:29
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine
2021-03-25 17:00
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development
2021-03-25 16:35
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar
2021-03-24 23:27
1
299
300
301
302
303
532